Glycomine, Inc. — Form D
Glycomine, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-10. The offering totals $12.6M, of which $4.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-11-10
- Form: D
- Accession: 0001689792-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.6M
- Amount sold: $4.9M
- Remaining: $7.7M
- Minimum investment: $10K
- Investors: 15
- Date of first sale: 2016-10-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-274291
Issuer
- Name: Glycomine, Inc.
- CIK: 0001689792
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: 4157947889
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Giacomo CM Chiesi | Director | San Francisco, CA |
| Peter CM McWilliams | Director | San Francisco, CA |
| Agnes Rafalko | Director | San Francisco, CA |
| Christopher CM Starr | Director | San Francisco, CA |
| Agnes Rafalko | Executive Officer | San Francisco, CA |
More